Keith M. Stolte

I'll research this attorney before drafting.

Keith M. Stolte — Patent Litigation Practice Summary

Focus areas. Stolte is a Chicago-based IP litigator whose patent work has centered on pharmaceutical/Hatch-Waxman matters — he represented generic manufacturer Tolmar in Galderma Labs., L.P. v. Tolmar, Inc. (N.D. Tex.) over adapalene gel formulations, and appeared for Sandoz in United Therapeutics Corp. v. Sandoz, Inc. (D.N.J.) on invalidity of a treprostinil patent. His broader docket is heavily trademark, copyright, unfair competition, false advertising, and trade secret focused, with patent litigation as one component; his most recent tracked patent matter involves autonomous floor-scrubbing robotics and navigation/sensor technology (Brain Corp. v. Avidbots). Public firm bios describe a client base spanning manufacturers, health care, software/internet, financial services, and universities rather than a single technical niche.

Side preference. His tracked history is limited and mixed rather than a consistent NPE/PAE or operating-company posture. The one tracked appearance is on the plaintiff/patent-owner side, but note a caption discrepancy: the structured list shows "Avidbots Corporation v. Brain Corporation," while the underlying N.D. Ill. docket is Brain Corporation v. Avidbots Corporation, No. 1:24-cv-12569, in which Stolte entered an appearance for plaintiff Brain Corporation (Dec. 6, 2024), asserting patents against Avidbots' Neo/Kas robots. Separately, his verified pharma work was on the defense side for generic-drug clients challenging branded patents. On balance he appears to work both sides, with an emphasis on defending manufacturers.

Firm context. He is a partner at TottisLaw (401 N. Michigan Ave., Chicago), which he joined in July 2019; the firm's practice is commercial and IP litigation where he typically serves as local counsel in N.D. Ill. matters. Before that he was a partner at McDermott Will & Emery in Chicago (Intellectual Property, Media & Technology Department), and he began his IP career as Intellectual Property Administrator at the Wm. Wrigley Jr. Company. He is also currently listed as Counsel at Maxson Mago & Macaulay (EM³ LLP), though I could not independently confirm the timing of that affiliation.

Notable cases / PTAB. Galderma Labs. v. Tolmar is his most significant verified patent result — the asserted adapalene formulation claims were held invalid for obviousness at the district court and the judgment was affirmed on appeal (Fed. Cir., 737 F.3d 731 (2013)). In the Avidbots dispute, Avidbots filed a series of IPRs (IPR2025-01600, -01602, -01604) against Brain Corporation patents covering robotic navigation and optical detection; the Board denied institution on discretionary grounds in March 2026. I found no public record of Stolte appearing as counsel in those PTAB proceedings — his tracked role was the district court case — so his IPR/PGR experience is not established by the sources reviewed.

Bar / education. J.D., magna cum laude, The John Marshall Law School (UIC), 1998; B.A., history, University of Chicago, 1987; admitted in Illinois (1998) and before several federal district and circuit courts, including the Federal Circuit. No USPTO patent-attorney registration number appears in his public profiles, so he should not be described as a registered patent attorney on the current record.